David Shaw’s ResMed RMD Stock Holding History

David Shaw’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-10,000	Closed	-$2.29M	–	4666
2024 Q4	$2.29M	Buy	+10,000	New	+$2.41M	﹤0.01%	2625
2022 Q4	–	Sell	-24,500	Closed	-$5.35M	–	5081
2022 Q3	$5.35M	Hold	24,500	–	–	0.01%	2013
2022 Q2	$5.14M	Hold	24,500	–	–	0.01%	2091
2022 Q1	$5.94M	Sell	24,500 -6,800	-22%	-$1.64M	0.01%	2121
2021 Q4	$8.15M	Hold	31,300	–	–	0.01%	1872
2021 Q3	$8.25M	Buy	+31,300	New	+$8.56M	0.01%	1663
2020 Q3	–	Sell	-44,800	Closed	-$8.6M	–	4105
2020 Q2	$8.6M	Sell	44,800 -7,100	-14%	-$1.16M	0.01%	1282
2020 Q1	$7.64M	Buy	51,900 +20,300	+64%	+$3.23M	0.01%	1158
2019 Q4	$4.9M	Buy	31,600 +24,500	+345%	+$3.53M	0.01%	1751
2019 Q3	$959K	Buy	+7,100	New	+$930K	﹤0.01%	2855
2016 Q1	–	Sell	-20,000	Closed	-$1.07M	–	3722
2015 Q4	$1.07M	Hold	20,000	–	–	﹤0.01%	2587
2015 Q3	$1.02M	Hold	20,000	–	–	﹤0.01%	2598
2015 Q2	$1.13M	Buy	20,000 +10,000	+100%	+$631K	﹤0.01%	2615
2015 Q1	$718K	Buy	+10,000	New	+$650K	﹤0.01%	2811

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

David Shaw's RMD Position: Q2 2026 in Review

David Shaw reduced its ResMed (RMD) stake by 47% in Q2 2026, selling an estimated $1.13M and leaving 6,121 shares worth $1.19M. The position accounts for ﹤0.01% of the portfolio, ranked #3622.

David Shaw first reported a position in RMD in Q2 2013 and has held it in 45 quarters since. The position peaked at $97.2M in Q3 2023. 880 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

David Shaw held 6,121 shares of ResMed worth $1.19M as of Q2 2026.
David Shaw sold 5,455 ResMed shares in Q2 2026, an estimated $1.13M.
ResMed made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #3622 holding.
David Shaw first reported a position in ResMed in Q2 2013 and has held it in 45 quarters since.
David Shaw's ResMed position peaked at $97.2M in Q3 2023.
880 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.